Search research articles
Contact Us
Filters
Showing results (191-200 of 201) with videos related to
Page
of 21
Sort By:
American Journal of Obstetrics and Gynecology
|
August 27, 2024
Corrigendum to 'Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length' Am J Obstet Gynecol 2009;201/4:375-377.e1-8
John Owen, Gary Hankins, Jay D Iams, et al.
The New England Journal of Medicine
|
March 31, 2016
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
Joshua D Lee, Peter D Friedmann, Timothy W Kinlock, et al.
American Journal of Obstetrics and Gynecology
|
October 1, 2009
Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length
John Owen, Gary Hankins, Jay D Iams, et al.
Cancer
|
November 12, 2024
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
Jayesh Desai, Andrew J Wagner, Irene Carrasco Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2018
Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial
Sandro Virgilio Porceddu, Mathias Bressel, Michael Geoffrey Poulsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
ACS Infectious Diseases
|
February 17, 2018
Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens
Ivelin S Georgiev, Michael Gordon Joyce, Rita E Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Kyung Hae Jung, Patricia LoRusso, Howard Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 201) with videos related to
Sort By:
Page
of 21
American Journal of Obstetrics and Gynecology
|
August 27, 2024
Corrigendum to 'Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length' Am J Obstet Gynecol 2009;201/4:375-377.e1-8
John Owen, Gary Hankins, Jay D Iams, et al.
The New England Journal of Medicine
|
March 31, 2016
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
Joshua D Lee, Peter D Friedmann, Timothy W Kinlock, et al.
American Journal of Obstetrics and Gynecology
|
October 1, 2009
Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length
John Owen, Gary Hankins, Jay D Iams, et al.
Cancer
|
November 12, 2024
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
Jayesh Desai, Andrew J Wagner, Irene Carrasco Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2018
Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial
Sandro Virgilio Porceddu, Mathias Bressel, Michael Geoffrey Poulsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 6, 2019
First-in-Humans Imaging with <sup>89</sup>Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.
ACS Infectious Diseases
|
February 17, 2018
Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens
Ivelin S Georgiev, Michael Gordon Joyce, Rita E Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Kyung Hae Jung, Patricia LoRusso, Howard Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, et al.
Page
of 21